The finding of PIK3R1, Notch1, and Mycn alterations as negative prognostic factors in molecular WHO Grade 4 astrocytomas may shed light on understanding the biobehavioral progression and also potential targeted therapies for this specific subset of astrocytomas. Here, MYCN is linked to astrocytoma (excluding glioblastoma).